(Q37729831)

22 August 2017

1 reference

title

Antiphospholipid syndrome: frequency, main causes and risk factors of mortality (English)

1 reference

antiphospholipid syndrome

22 August 2017

main subject

1 reference

inferred from title

author

Ricard Cervera i Segura

series ordinal

2

object named as

Ricard Cervera

1 reference

22 August 2017

1

Gerard Espinosa

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 April 2010

1 reference

Nature Reviews Rheumatology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

296-300

1 reference

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

The management of thrombosis in the antiphospholipid-antibody syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Thrombotic storm: when thrombosis begets thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.47

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals

31 March 2020

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome and sepsis. A common link?

1 reference

12 December 2020

Primary antiphospholipid syndrome: functional outcome after 10 years

1 reference

12 December 2020

The catastrophic antiphospholipid syndrome

1 reference

12 December 2020

The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.47

1 reference

22 August 2017

1 reference